Medicine and Dentistry
Psoriasis
100%
Association
58%
Patient
48%
Disease
30%
Biological Marker
29%
Analysis
24%
Therapeutic Procedure
22%
Atopic Dermatitis
21%
Treatment Response
20%
Meta-Analysis
20%
Skin
20%
Acneiform Eruption
18%
Genome Wide Association Study
18%
Inflammatory Disorder
17%
Gene
16%
Biological Product
14%
Genetic Risk
14%
Ustekinumab
13%
Psoriatic Arthritis
13%
Odds Ratio
12%
Allele
12%
Pustular Psoriasis
12%
Comorbidity
12%
Psoriasis Area and Severity Index
12%
Genetic Risk Factor
12%
Woman
12%
Genotype
11%
Scar Formation
11%
Protein
10%
Pustulosis Palmaris Et Plantaris
10%
Biological Therapy
10%
Systemic Therapy
10%
Cross Sectional Study
10%
Cytokine
10%
TNF Inhibitor
10%
Mediator
10%
Dermatosis
9%
COVID-19
9%
Morphogenesis
9%
Hair Follicle
9%
Ovary Follicle Development
9%
Immunopathology
9%
Death
9%
Gene Expression
9%
Disease
9%
Inpatient
9%
Disease Exacerbation
9%
Generalized Pustular Psoriasis
9%
Genetic Difference
9%
Serum
9%
Biochemistry, Genetics and Molecular Biology
Association
54%
Genetics
42%
Nested Gene
42%
Allele
34%
Phenotype
26%
HLA-C
24%
Age
22%
Development
20%
HLA-B
19%
Genome-Wide Association Study
19%
Exome Sequencing
18%
Genetic Heterogeneity
18%
Genetic Risk
17%
Mutation
15%
Genetic Divergence
14%
Protein
14%
Adalimumab
14%
Exome
14%
Electric Potential
13%
Major Histocompatibility Complex
12%
Prevalence
11%
Genotyping
11%
Interleukin
11%
Genetic Architecture
11%
Waist Circumference
10%
Heritability
10%
Mediator
10%
Gene Expression
9%
Folliculogenesis
9%
Interferon Type I
9%
Antibody
9%
Morphogenesis
9%
Amino Acids
9%
T Cell
9%
Learning
9%
Gene Signature
9%
Coding
9%
Peptide
9%
HLA-DR
9%
Association Mapping
9%
Genetic Difference
9%
Comorbidity
8%
Position
8%
Sample Size
7%
Biomarker Study
5%
Smoking
5%
Sample
5%
Immunology and Microbiology
Association
51%
Biological Product
24%
Adalimumab
23%
Ustekinumab
22%
Age
18%
Atopic Dermatitis
18%
Monospecific Antibody
18%
COVID-19
18%
Allele
16%
Phenotype
16%
Comorbidity
15%
Skin
15%
Gene
14%
Major Histocompatibility Complex
12%
Genotype
11%
Psoriatic Arthritis
11%
Immune-Mediated Inflammatory Diseases
11%
Scar Formation
11%
Drug Antibody
10%
TNF Inhibitor
10%
Genetic Variability
10%
Genome-Wide Association Study
10%
Electric Potential
10%
Dendritic Cell
9%
Gene Expression
9%
Interleukin Derivative
9%
HLA-DR
9%
Coding
9%
Pustulosis
9%
Mutation
9%
Pharmacodynamics
9%
Pharmacokinetics
9%
Development
9%
Position
8%
Prevalence
7%
Interleukin-6
7%
Nail
5%
Tissues
5%
Mediator
5%
Interleukin 17
5%
Inflammatory Disorder
5%
